HOME > 教室について > 業績リスト > 【発表論文】英文 > 2010年

2010年

  1. Nakagawa Y, Kimura T, Morimoto T, Nomura M, Saku K, Haruta S, Muramatsu T, Nobuyoshi M, Kadota K, Fujita H, Tatami R, Shiode N, Nishikawa H, Shibata Y, Miyazaki S, Murata Y, Honda T, Kawasaki T, Doi O, Hiasa Y, Hayashi Y, Matsuzaki M, Mitsudo K; j-Cypher Registry Investigators. Incidence and Risk Factors of Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation (3-Year Follow-Up of the j-Cypher Registry). Am J Cardiol. 2010 Aug 1; 106(3): 329-336. Epub 2010 Jun 18.
  2. Ozasa N, Morimoto T, Furukawa Y, Hamazaki H, Kita T, Kimura T: Six-Minute Walk Distance in Japanese Healthy Adults. General Medicine Vol.11, No.1 p.25-30, June, 2010.
  3. Kimura T, Morimoto T, Kozuma K, Honda Y, Kume T, Aizawa T, Mitsudo K, Miyazaki S, Yamaguchi T, Hiyoshi E, Nishimura E, Isshiki T; RESTART Investigators. Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: Observations from the Registry of Stent Thrombosis for Review and Reevaluation (RESTART). Circulation. 2010 Jul 6; 122(1): 52-61. Epub 2010 Jun 21.
  4. Kohsaka S, Kimura T, Goto M, Lee VV, Elayda M, Furukawa Y, Fukushima M, Komeda M, Sakata R, Willerson JT, Wilson JM, Kita T. Difference in patient profiles and outcomes in Japanese versus American patients undergoing coronary revascularization (collaborative study by CREDO-Kyoto and the Texas Heart Institute Research Database). Am J Cardiol. 2010 Jun 15; 105(12): 1698-704. Epub 2010 May 4.
  5. Shirai S, Kimura T, Nobuyoshi M, Morimoto T, Ando K, Soga Y, Yamaji K, Kondo K, Sakai K, Arita T, Goya M, Iwabuchi M, Yokoi H, Nosaka H, Mitsudo K; j-Cypher Registry Investigators. Impact of multiple and long sirolimus-eluting stent implantation on 3-year clinical outcomes in the j-Cypher Registry. JACC Cardiovasc Interv. 2010 Feb; 3(2): 180-8.
  6. Abe M, Kimura T, Morimoto T, Taniguchi T, Yamanaka F, Nakao K, Yagi N, Kokubu N, Kasahara Y, Kataoka Y, Otsuka Y, Kawamura A, Miyazaki S, Nakao K, Horiuchi K, Ito A, Hoshizaki H, Kawaguchi R, Setoguchi M, Inada T, Kishi K, Sakamoto H, Morioka N, Imai M, Shiomi H, Nonogi H, Mitsudo K; j-Cypher Registry Investigators. Sirolimus-eluting stent versus balloon angioplasty for sirolimus-eluting stent restenosis: Insights from the j-Cypher Registry. Circulation. 2010 Jul 6; 122(1): 42-51. Epub 2010 Jun 21.
  7. Ehara N, Morimoto T, Furukawa Y, Shizuta S, Taniguchi R, Nakagawa Y, Hoshino K, Saito N, Doi T, Haruna Y, Ozasa N, Imai Y, Teramukai S, Fukushima M, Kita T, Kimura T. Effect of baseline glycemic level on long-term cardiovascular outcomes after coronary revascularization therapy in patients with type 2 diabetes mellitus treated with hypoglycemic agents. Am J Cardiol. 2010 Apr 1; 105(7): 960-6. Epub 2010 Feb 13.
  8. Hiro T, Kimura T, Morimoto T, Miyauchi K, Nakagawa Y, Yamagishi M, Ozaki Y, Kimura K, Saito S, Yamaguchi T, Daida H, Matsuzaki M; JAPAN-ACS Investigators. Diabetes mellitus is a major negative determinant of coronary plaque regression during statin therapy in patients with acute coronary syndrome--serial intravascular ultrasound observations from the Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome Trial (the JAPAN-ACS Trial). Circ J. 2010 May 25; 74(6): 1165-74. Epub 2010 May 12.
  9. Ikeda T, Taniguchi R, Watanabe S, Kawato M, Kondo H, Shirakawa R, Yamane K, Toma M, Tamura T, Takahashi K, Watanabe H, Yoshikawa Y, Tabuchi A, Kita T, Kimura T, Horiuchi H. Characterization of the antiplatelet effect of aspirin at enrollment and after 2-year follow-up in a real clinical setting in Japan. Circ J. 2010 May 25; 74(6): 1227-35. Epub 2010 Apr 10.
  10. Ozasa N, Kimura T, Morimoto T, Hou H, Tamura T, Shizuta S, Nakagawa Y, Furukawa Y, Hayashi Y, Nakao K, Matsuzaki M, Nobuyoshi M, Mitsudo K, on Behalf of the j-Cypher Registry Investigators. Lack of Effect of Oral Beta-Blocker Therapy at Discharge on Long-Term Clinical Outcomes of ST-Segment Elevation Acute Myocardial Infarction after Primary Percutaneous Coronary Intervention. Am J Cardiol. 2010 Nov 1; 106(9): 1225-33. Epub 2010 Sep 9.
  11. Kawaguchi R, Kimura T, Morimoto T, Oshima S, Hoshizaki H, Kawai K, Shiode N, Hiasa Y, and Mitsudo K, for the j-Cypher Registry Investigators. Safety and Efficacy of Sirolimus-Eluting Stent Implantation in Patients with Acute Coronary Syndrome in the Real World American journal of cardiology. Am J.Cardiol.2010Dec1: 106 (11) 1550-60.
  12. Ohashi T, Shibata R, Morimoto T, Kanashiro M, Ishii H, Ichimiya S, Hiro T, Miyauchi K, Nakagawa Y, Yamagishi M, Ozaki Y, Kimura T, Daida H, Murohara T, Matsuzaki M. Correlation between circulating adiponectin levels and coronary plaque regression during aggressive lipid-lowering therapy in patients with acute coronary syndrome: subgroup analysis of JAPAN-ACS study. Atherosclerosis. 2010 Sep; 212(1): 237-42. Epub 2010 May 11.
  13. Yamaji K, Kimura T, Morimoto T, Nakagawa Y, Inoue K, Soga Y, Arita T, Shirai S, Ando K, Kondo K, Sakai K, Goya M, Iwabuchi M, Yokoi H, Nosaka H, Nobuyoshi M. Very Long-Term (15 to 20 Years) Clinical and Angiographic Outcome After Coronary Bare Metal Stent Implantation. Circ Cardiovasc Interv. 2010 Sep 7. [Epub ahead of print]
  14. Saito N, Shimamoto T, Takeda T, Marui A, Kimura T, Ikeda T, et al. Excimer laser-assisted retrieval of Günther Tulip vena cava filters: a pilot study in a canine Model. Journal of vascular and interventional radiology. 2010; 21(5): 719-24.
  15. Tada T, Fujita M, Goto T, Tamura T, Ono K, Kita T, Takahashi K, Osada H, Sakata R, Kimura T: A Case with Sudden Onset of Position-dependent Hypoxemia Caused by Reopening of Foramen Ovale. Journal of Cardiology Cases. 2010; 1(2): e88-e91.
  16. Kume N, Mitsuoka H, Hayashida K, Tanaka M, Kita T: Soluble lectin-like oxidized low density lipoprotein receptor-1 (sLOX-1) predicts prognosis after acute coronary syndrome –A pilot study. Circ. J. vol. 74: 1399-1404, 2010
  17. Nakamura M, Ohta H, Kume N, Hayashida K, Tanaka M, Mitsuoka H, Kaneshige T, Misaki S, Imagawa K, Shimosako K, Ogawa N, Kita T, Kominami G: Generation of monoclonal antibodies against a soluble form of lectin-like oxidized low-density lipoprotein receptor-1 and development of a sensitive chemiluminescent enzyme immunoassay. J. Pharm. Biomed. vol. 51: 158-163, 2010
  18. Kojima Y, Ishida T, Sun L, Yasuda T, Toh R, Rikitake Y, Fukuda A, Kume N, Koshiyama H, Taniguchi A, Hirata K: Pitavastatin decreases the expression of endothelial lipase both in vitro and in vivo. Cardiovasc. Res. vol. 87: 385-393, 2010
  19. Kume N, Mitsuoka H, Hayashida K, Tanaka M, Kominami G, Kita T: Soluble lectin-like oxidized low density lipoprotein receptor-1 (sLOX-1) as a sensitive and specific biomarker for acute coronary syndrome –Comparison with other biomarkers. J. Cardiol. vol. 56: 159-165, 2010
  20. T.E. Brinkley, X. Wang, Kume N, Mitsuoka H, B.J. Nicklas: Caloric restriction, aerobic exercise training, and soluble lectin-like oxidized LDL receptor-1 levels in overweight and obese postmenopausal women. Int. J. Obesity. 21 September, 2010
  21. Kobayashi N, Hata N, Kume N, Seino Y, Inami T, Yokoyama S, Shinada T, Tomita K, Kaneshige T, Mizuno K: Soluble lectin-like oxidized low-density lipoprotein receptor-1 as an early biomarker for ST elevation myocardial infarction: Time-dependant comparison with other biomarkers. Cir. J. 2011 in press
  22. Kato T, Niizuma S, Inuzuka Y, Kawashima T, Okuda J, Tamaki Y, Iwanaga Y, Narazaki M, Matsuda T, Soga T, Kita T, Kimura T, Shioi T. Analysis of Metabolic Remodeling in Compensated Left Ventricular Hypertrophy and Heart Failure. Circ Heart Fail. 3: 420-30; 2010.
  23. Lin RC, Weeks KL, Gao XM, Williams RB, Bernardo BC, Kiriazis H, Matthews VB, Woodcock EA, Bouwman RD, Mollica JP, Speirs HJ, Dawes IW, Daly RJ, Shioi T, Izumo S, Febbraio MA, Du XJ, McMullen JR: PI3K (p110alpha) protects against myocardial infarction-induced heart failure: identification of PI3K-regulated miRNA and mRNA. Arterioscler Thromb Vasc Biol. 4: 724-32；2010.
  24. Horie T, Ono K, Horiguchi M, Nishi H, Nakamura T, Nagao K, Kinoshita M, Kuwabara Y, Marusawa H, Iwanaga Y, Hasegawa K, Yokode M, Kimura T, Kita T: MicroRNA-33 encoded by an intron of Srebp2 regulates HDL in vivo Proc Natl Acad Sci U S A. 2010; 107:17321-6.
  25. Horie T, Ono K, Nishi H, Nagao K, Kinoshita M, Watanabe S, Kuwabara Y, Nakashima Y, Takanabe-Mori R, Nishi E, Hasegawa K, Kita T, Kimura T: Acute Doxorubicin Cardiotoxicity Is Associated with miR-146a-induced Inhibition of the Neuregulin-ErbB Pathway Cardiovascular Res 2010;87:656-664.
  26. Nishi H, Ono K, Iwanaga Y, Horie T, Nagao K, Takemura G, Kinoshita M, Kuwabara Y, Takanabe Mori R, Hasegawa K, Kita T, Kimura T: MicroRNA-15b modulates cellular ATP levels and degenerates mitochondria via ARL2 in neonatal rat cardiac myocytes. J Biol Chem. 2010; 285:4920-30.
  27. Nagao K, Ono K, Iwanaga Y, Tamaki Y, Kojima Y, Horie T, Nishi H, Kinoshita M, Kuwabara Y, Hasegawa K, Kita T, Kimura T: Neural cell adhesion molecule is a cardioprotective factor up-regulated by metabolic stress. Journal of Molecular and Cellular Cardiology. 2010; 48:1157-68.
  28. Kinoshita M, Ono K, Horie T, Nagao K, Nishi H, Kuwabara Y, Takanabe-Mori R, Hasegawa K, Kita T, and Kimura T: Regulation of adipocyte differentiation by activation of serotonin (5-HT) receptors 5-HT2AR and 5-HT2CR and involvement of microRNA-448-mediated repression of KLF5. Molecular Endoclinology. 2010; 24:1978-87.
  29. Watanabe S, Tamura T, Ono K, Horiuchi H, Kimura T, Kita T, Furukawa Y: Insulin-like growth factor axis (insulin-like growth factor-I/insulin-like growth factor-binding protein-3) as a prognostic predictor of heart failure: association with adiponectin. Eur J Heart Failure 2010; 12: 1214-22.
  30. Ono K, Wang X, Kim SO, Armstrong LC, Bornstein P, Han J: Metaxin deficiency alters mitochondrial membrane permeability and leads to resistance to TNF-induced cell killing. Protein Cell 2010; 1: 161-173.
  31. Takanabe-Mori R, Ono K, Sowa N, Takaya T, Horie T, Satoh-Asahara N, Shimatsu A, Fujita M, Sawamura T, Hasegawa K: LOX-1 is required for the adipose tissue expression of proinflammatory cytokines in high-fat diet-induced obese mice. Biochem Biophys Res Commun 2010; 398: 576-80.
  32. Kaichi S, Hasegawa K, Takaya T, Yokoo N, Mima T, Kawamura T, Morimoto T, Ono K, Baba S, Doi H, Yamanaka S, Nakahata T, Heike T: Cell line-dependent differentiation of induced pluripotent stem cells into cardiomyocytes in mice. Cardiovasc Res. 2010; 88: 314-23.
  33. Wada H, Shinjo D, Kameda S, Ono K, Satoh N, Morimoto T, Osakada G, Nakano T, Fujita M, Shimatsu A, Hasegawa K: Transmitral E/A ratio decreases in association with abdominal fat accumulation in patients with impaired glucose tolerance or mild diabetes without left ventricular hypertrophy. Heart Vessels. 2010; 25: 45-50.
  34. Wada H, Satoh N, Kitaoka S, Ono K, Morimoto T, Kawamura T, Nakano T, Fujita M, Kita T, Shimatsu A, Hasegawa K: Soluble VEGF receptor-2 is increased in sera of subjects with metabolic syndrome in association with insulin resistance. Atherosclerosis 2010; 208:512-517
  35. Tada T, Fujita M, Goto T, Tamura T, Ono K, Kita T, Takahashi K, Nagata H, Sakata R, Kimura T: A case with sudden onset of position-dependent hypoxemia caused by reopening of foramen ovale. Journal of Cardiology Cases 2010; 1:e88-e91.
  36. Tian Y, Yuan Z, Liu Y, Liu W, Zhang W, Xue J, Shen Y, Liang X, Chen T, Kishimoto C: Pioglitazone modulates the balance of effector and regulatory T cells in apolipoprotein E deficient mice. Nutrition, Metabolism & Cardiovascular Disease (in press).
  37. Xue JH, Yuan Z, Wu Y, Liu Y, Zhao Y, Zhang WP, Tian YL, Liu WM, Liu Y, Kishimoto C: High glucose promotes intracellular lipid accumulation in vascular smooth muscle cells by impairing cholesterol influx and efflux balance. Cardiovasc. Res. 86,141-150,2010.
  38. Shimada K, Murayama T, Yokode M, Kita T, Fujita M, Kishimoto C: Olmesartan, a novel angiotensin II type 1 receptor antagonist, reduces severity of atherosclerosis in apolipoprotein E deficient mice associated with reducing superoxide production. Nutrition, Metabolism & Cardiovascular Disease (in press).
  39. Shimada K, Okabe T, Mikami Y, Hattori M, Fujita M, Kishimoto C: Therapy with granulocyte colony-stimulating factor in the chronic stage, but not in the acute stage, improves experimental autoimmune myocarditis in rats via nitric oxide. J. Moll. Cell. Cardiol. 49,469-481,2010.
  40. Shimada K, Murakami Y, Murayama T, Yokode M, Fujita M, Kita T, Kishimoto C: Atherosclerotic plaques induced by marble-buring befavior are stabilized by exercise training in experimental atherosclerosis. Int J Cardiol (in press).
  41. Zhao Y, Liu Y, Zhang W, Xue J, Wu YZ, Xu W, Liang X, Chen T, Kishimoto C, Yuan Z: Win 55212-2 ameliorates astherosclerosis associated with suppression of pro-inflammatory responses in ApoE-knockout mice. Eur J Pharmacol 649,2895-292,2010.
  42. Kishimoto C, Shimada K: Antioxidants reduce the severity of atherosclerosis. Website of International Atherosclerosis Society. Jan.8, 2010.
  43. Weng H, Shen C, Hirokawa G, Ji X, Takahashi R, Shimada K, Kishimoto C, Iwai N: Plasma miR-124 as a biomarker for cerebral infarction. Biomedical Research (in press).
  44. Yui Y, Kodama K, Hirayama A, Nishio R, Iwanaga Y, Nonogi H, Haze K, Sumiyoshi T, Yui N, Hosoda S, Kawai C; Japan Multicenter Investigation for Cardiovascular Diseases B (JMIC-B) Study Group: Reverse remodeling and improved function by antihypertensive treatment in hypertensive patients with coronary artery disease, J Hypertens. 28:178-185, 2010
  45. Doi T, Makiyama T, Morimoto T, Haruna Y, Tsuji K, Akao M, Takahashi Y, Kimura T, Horie M: A novel KCNJ2 nonsense mutation, S369X, impedes trafficking and causes a limited form of Andersen-Tawil　Syndrome. Circulation Cardiovascular Genetics. In press.
  46. Ohno S, Zankov D, Ding W, Makiyama T, Doi T, Shizuta S, Itoh H, Nishio Y, Hattori T, Matsuura H, Horie M: Novel KCNE5 variants are associated with Brugada syndrome and idiopathic ventricular fibrillation. Circulation Arrhythmia and Electrophysiol. In press.
  47. Miyamoto A, Hayashi H, Makiyama T, Yoshino T, Mizusawa Y, Sugimoto Y, Ito M, Xue JQ, Murakami Y, Horie M: Risk Determinants in Individuals With a Spontaneous Type 1 Brugada ECG. Circ J. 2011 Feb 18.
  48. Oka Y, Itoh H, Ding WG, Shimizu W, Makiyama T, Ohno S, Nishio Y, Sakaguchi T, Miyamoto A, Kawamura M, Matsuura H, Horie M: Atrioventricular block-induced Torsades de Pointes with clinical and molecular backgrounds similar to congenital long QT syndrome. Circ J. 2010 Nov 25; 74(12): 2562-71.
  49. Nagaoka I, Shimizu W, Mizusawa Y, Sakaguchi T, Itoh H, Ohno S, Makiyama T, Yamagata K, Makimoto H, Miyamoto Y, Kamakura S, Horie M: Heart rate-dependent variability of cardiac events in type 2 congenital long-QT syndrome. Europace. 2010 Nov; 12(11): 1623-9.
  50. Itoh H, Shimizu W, Hayashi K, Yamagata K, Sakaguchi T, Ohno S, Makiyama T, Akao M, Ai T, Noda T, Miyazaki A, Miyamoto Y, Yamagishi M, Kamakura S, Horie M: Long QT syndrome with compound mutations is associated with a more severe phenotype: a Japanese multicenter study. Heart Rhythm. 2010 Oct; 7(10): 1411-8.
  51. Watanabe H, Makiyama T, Koyama T, Kannankeril PJ, Seto S, Okamura K, Oda H, Itoh H, Okada M, Tanabe N, Yagihara N, Kamakura S, Horie M, Aizawa Y, Shimizu W: High prevalence of early repolarization in short QT syndrome. Heart Rhythm. 2010 May; 7(5): 647-52.
  52. Masuda S, Oda Y, Sasaki H, Ikenouchi J, Higashi T, Akashi M, Nishi E, and Furuse M. Angulin/LSR defines cell corners for tricellular tight junction formation in epithelial cells. J. Cell. Sci. in press
  53. Furuyama K, Kawaguchi Y, Akiyama H, Horiguchi M, Kodama S, Kuhara T, Hosokawa, S Elbahrawy A, Soeda T, Koizumi M, Masui T, Kawaguchi M, Takaori K, Doi R, Nishi E, Kakinoki R, Deng JM, Behringer RR, Nakamura T, and Uemoto S: Continuous cell supply from the Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat. Genet. in press
  54. Tanaka M, Asada M, Yoshioka-Higashi A, Nakamura J, Oguchi A, Tomita M, Yamada S, Asada N, Takase M, Okuda T, Kawachi H, Aris N. Economides, Elizabeth Robertson, Takahashi S, Sakurai T, Roel Goldschmeding, Muso E, Fukatsu A, Kita T, and Yanagita M: Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome, J Clin Invest. 120(3): 768-77, 2010.
  55. Nakamura J, Yanagita M: Bone morphogenetic proteins and kidney disease. Discovery Medicine in press.
  56. Yanagita M: Antagonists of bone morphogenetic proteins in kidney diseases. Curr Opin Invest Drugs 11(3): 315-22, 2010.
  57. Yokoo T, Yanagita M：Stem cell therapy against oxidative stress and hypoxia.“Oxidative Stress and Hypoxia in Renal Disorders”, edited by Kai-Uwe Eckardt and Toshio Miyata, published from The Human Press/Springer Science, in press.
  58. Yoshida Y, Morimoto T, Takaya T, Kawamura T, Sunagawa Y, Wada H, Fujita M, Shimatsu A, Kita T, Hasegawa K: Aldosterone signaling associates with p300/GATA4 transcriptional pathway during the hypertrophic response of cardiomyocytes. Circ. J. 74(1): 156-162, 2010.
  59. Fukuda S, Shimada K, Kawasaki T, Kono Y, Jissho S, Taguchi H, Maeda K, Yoshiyama M, Fujita M, Yoshikawa J: “Passive exercise” using whole body periodic acceleration: effects on coronary microcirculation. Am. Heart. J. 159(4): 620-626, 2010.
  60. Matsumoto T, Fujita M, Sawamura T, Kakino A, Sato Y, Fujita Y, Matsuda H, Nakanishi M, Uchida K, Nakae I, Kanda H, Yoshida A, Miwa K, Hayashi H, Mitsunami K, Horie M: Pitavastatin reduces lectin-like oxidized low-lipoprotein receptor-1 ligands in hypercholesterolemic humans. Lipids. 45(4): 329-335, 2010.
  61. Takaya T, Wada H, Morimoto T, Sunagawa Y, Kawamura T, Takanabe-Mori R, Shimatsu A, Fujita Y, Sato Y, Fujita M, Kimura T, Sawamura T, Hasegawa K: Left ventricular expression of lectin-like oxidized low-density lipoprotein receptor-1 in failing rat hearts. Circ. J. 74(4): 723-729, 2010.
  62. Katashima T, Naruko T, Terasaki F, Fujita M, Otsuka K, Murakami S, Sato A, Hiroe M, Ikura Y, Ueda M, Ikemoto M, Kitaura Y: Enhanced expression of the S100A8/A9 complex in acute myocardial infarction patients. Circ. J. 74(4): 741-748, 2010.
  63. Sunagawa Y, Morimoto T, Takaya T, Kaichi S, Wada H, Kawamura T, Fujita M, Shimatsu A, Kita T, Hasegawa K: Cyclin-dependent kinase-9 is a component of the p300/GATA4 complex required for phenylephrine-induced hypertrophy in cardiomyocytes. J. Biol. Chem. 285(13): 9556-9568, 2010.
  64. Morimoto T, Sunagawa Y, Fujita M, Hasegawa K: Novel heart failure therapy targeting transcriptional pathway in cardiomyocytes by a natural compound, curcumin. Circ. J. 74(6): 1059-1066, 2010.
  65. Fujita M, Sasayama S: Coronary collateral growth and its therapeutic application to coronary artery disease. Circ. J. 74(7): 1283-1289, 2010.
  66. Kohro T, Fujita M, Sasayama S, Mitani S, Yamazaki T, Hayashi D, Okada Y, Nagai R, for the JCAD Study Investigators: Prognostic effects of combined treatment with calcium channel blocker and statins in patients with coronary narrowing: From the Japanese Coronary Artery Disease Study. Int. Heart. J. 51(5): 299-302, 2010.
  67. Higashi Y, Fujita M, Origasa H, Miyata T, Matsuo H, Naritomi H, Shigematsu H: Study design of SEASON registry: Prospective surveillance of cardiovascular events in antiplatelet-treated arteriosclerosis obliterans patients in JapaN. Int. Heart. J. 51(5): 337-342, 2010.
  68. Yamanaka K, Sekine Y, Nonaka M, Iwakura A, Yoshitani K, Nakagawa Y, Fujita M: Left atrial appendage contributes to left atrial booster function after the maze procedure: quantitative assessment with multidetector computed tomography. Eur. J. Cardiothorac. Surg. 38(3): 361-365, 2010.
  69. Miwa K, Fujita M: Fluctuation of serum vitamin E (α-tocopherol) concentrations during exacerbation and remission phases in patients with chronic fatigue syndrome. Heart. Vessels. 25(4): 319-323, 2010.
  70. Fujita M, Sasayama S, Terasaki F, Mitani S, Morimoto T, Yamazaki T, Hayashi D, Kohro T, Okada Y, Nagai R, The JCAD Study Investigators: Treatment effects of renin-angiotensin system inhibitor and calcium channel blocker in patients with coronary artery narrowing (from the Japanese Coronary Artery Disease Study). Heart. Vessels. 25(6): 453-459, 2010.
  71. Tarumi T, Takebayashi S, Fujita M, Nakano T, Ito M, Yamakado T: Pacing tachycardia exaggerates left ventricular diastolic dysfunction but not systolic function and regional asynergy or asynchrony in patients with hypertrophic cardiomyopathy. Europace. 12(9): 1308-1315, 2010.
  72. Fujita M, Sasayama S: Reappraisal of functional importance of coronary collateral circulation. Cardiology. 117(4): 246-252, 2010.
<< 2009年｜ 業績リストTOP ｜2011年 >>
ページの先頭へ